Paclitaxel protein-bound Intravenous and Tarceva

• Generic Name: paclitaxel protein-bound
• Dosage Forms: n.a.
• Other Brand Names: Abraxane

Paclitaxel protein-bound injection is used to treat metastatic breast cancer (cancer that has already spread) after other treatments have failed. It is used together with carboplatin, a cancer medicine, to treat advanced or metastatic non-small cell lung cancer in patients who cannot receive radiation therapy or have surgery. Paclitaxel protein-bound is used together with gemcitabine, a cancer medicine, to treat metastatic pancreas cancer.

Paclitaxel belongs to the group of medicines called antineoplastics (cancer medicines). It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by paclitaxel, other unwanted effects will also occur.

Paclitaxel protein-bound is to be given only by or under the direct supervision of a doctor.

• Generic Name: erlotinib
• Dosage Forms: tablet
• Other Brand Names: Tarceva

Tarceva (erlotinib) is a cancer medicine that interferes with the growth of cancer cells and slows their spread in the body.

Tarceva is used to treat non-small cell lung cancer or pancreatic cancer that has spread to other parts of the body (metastatic).

Tarceva is usually given after other cancer medicines have been tried without success.